Publication Name	World Journal of Pharmacology
Manuscript ID	83400
Country	United States

Received	2023-01-20 23:34
Peer-Review Started	2023-01-20 23:36
To Make the First Decision
Return for Revision	2023-04-28 03:19
Revised	2023-05-10 14:05
Second Decision	2023-05-31 03:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-05-31 08:01
Articles in Press	2023-05-31 08:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-06-14 01:42
Publish the Manuscript Online	2023-06-15 08:11

ISSN	2220-3192 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Minireviews
Article Title	Commentary: Discussing the antidepressant potential of silymarin
Manuscript Source	Invited Manuscript
All Author List	Claire E Manhard and Brandon Lucke-Wold
Funding Agency and Grant Number
Corresponding Author	Brandon Lucke-Wold, MD, PhD, Neurosurgeon, Department of Neurosurgery, University of Florida, 1505 SW Archer Rd, Gainesville, FL 32608, United States. brandon.lucke-wold@neurosurgery.ufl.edu
Key Words	Silymarin; Depression; Anxiety; Phytochemicals; Nutraceuticals; Curcumin
Core Tip	There are several reviews focused on the role of silymarin (SILY) in chronic diseases, however, there is a paucity of literature reviewing the potential antidepressant effects of SILY. This commentary serves as a discussion of the recent findings regarding the antioxidant, anti-inflammatory, and antidepressant-like potential of SILY in mice and as a catalyst for future discovery in phytochemistry.
Publish Date	2023-06-15 08:11
Citation	Manhard CE, Lucke-Wold B. Commentary: Discussing the antidepressant potential of silymarin. World J Pharmacol 2023; 12(3): 18-24
URL	https://www.wjgnet.com/2220-3192/full/v12/i3/18.htm
DOI	https://dx.doi.org/10.5497/wjp.v12.i3.18

Full Article (PDF)	WJP-12-18-with-cover.pdf
Full Article (Word)	WJP-12-18.docx
Manuscript File	83400_Auto_Edited-JLW.docx
Answering Reviewers	83400-Answering reviewers.pdf
Audio Core Tip	83400-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	83400-Conflict-of-interest statement.pdf
Copyright License Agreement	83400-Copyright license agreement.pdf
Peer-review Report	83400-Peer-review(s).pdf
Scientific Misconduct Check	83400-Bing-Wang JJ-2.png
Scientific Editor Work List	83400-Scientific editor work list.pdf